Scarborough Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Scarborough Advisors's BMY Position: Q2 2026 in Review
Scarborough Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 1,793 shares — an estimated $109K sold.
Scarborough Advisors first reported a position in BMY in Q4 2023 and held it in 2 quarters. The position peaked at $109K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Scarborough Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Scarborough Advisors sold 1,793 Bristol-Myers Squibb shares in Q2 2026, an estimated $109K.
- Scarborough Advisors first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 2 quarters.
- Scarborough Advisors's Bristol-Myers Squibb position peaked at $109K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.